We Analyzed the Future Direction of Encompass Health Corporation (EHC), Here is What We Found – News Heater
Home  »  Companies   »  We Analyzed the Future Direction of Encompass Heal...

We Analyzed the Future Direction of Encompass Health Corporation (EHC), Here is What We Found

Encompass Health Corporation (NYSE:EHC) went down by -4.31% from its latest closing price compared to the recent 1-year high of $85.75. The company’s stock price has collected -3.86% of loss in the last five trading sessions.

Is It Worth Investing in Encompass Health Corporation (NYSE :EHC) Right Now?

Encompass Health Corporation (NYSE:EHC) scored a price-to-earnings ratio above its average ratio, recording 13.80 x from its present earnings ratio. Plus, the 36-month beta value for EHC is at 1.01. Opinions of the stock are interesting as 12 analysts out of 13 who provided ratings for Encompass Health Corporation declared the stock was a “buy,” while 1 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $78.58, which is $25.48 above the current price. EHC currently public float of 97.77M and currently shorts hold a 3.23% ratio of that float. Today, the average trading volume of EHC was 700.61K shares.

EHC’s Market Performance

EHC stocks went down by -3.86% for the week, with a monthly drop of -15.72% and a quarterly performance of -22.25%, while its annual performance rate touched -33.87%. The volatility ratio for the week stands at 3.44% while the volatility levels for the past 30 days are set at 2.81% for Encompass Health Corporation. The simple moving average for the period of the last 20 days is -12.03% for EHC stocks with a simple moving average of -18.94% for the last 200 days.

Analysts’ Opinion of EHC

Many brokerage firms have already submitted their reports for EHC stocks, with UBS repeating the rating for EHC by listing it as a “Buy.” The predicted price for EHC in the upcoming period, according to UBS is $98 based on the research report published on September 24th of the previous year 2021.

Raymond James, on the other hand, stated in their research note that they expect to see EHC reach a price target of $107, previously predicting the price at $95. The rating they have provided for EHC stocks is “Strong Buy” according to the report published on August 02nd, 2021.

Barclays gave a rating of “Overweight” to EHC, setting the target price at $96 in the report published on November 23rd of the previous year.

EHC Trading at -17.43% from the 50-Day Moving Average

After a stumble in the market that brought EHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.05% of loss for the given period.

Volatility was left at 2.81%, however, over the last 30 days, the volatility rate increased by 3.44%, as shares sank -16.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.15% lower at present.

During the last 5 trading sessions, EHC fell by -3.86%, which changed the moving average for the period of 200-days by -33.20% in comparison to the 20-day moving average, which settled at $60.83. In addition, Encompass Health Corporation saw -17.28% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at EHC starting from O’Connor Kevin J., who purchase 1,000 shares at the price of $66.48 back on May 06. After this action, O’Connor Kevin J. now owns 3,436 shares of Encompass Health Corporation, valued at $66,480 using the latest closing price.

Williams Terrance, the Director of Encompass Health Corporation, purchase 354 shares at $56.61 during a trade that took place back on Dec 02, which means that Williams Terrance is holding 5,258 shares at $20,040 based on the most recent closing price.

Stock Fundamentals for EHC

Current profitability levels for the company are sitting at:

  • +15.75 for the present operating margin
  • +19.60 for the gross margin

The net margin for Encompass Health Corporation stands at +8.02. Equity return is now at value 20.90, with 5.80 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 1.23.

Is Bitfarms Ltd. (BITF) a Keeper?

Bitfarms Ltd. (NASDAQ:BITF) went down by -7.33% from its latest closing price compared to the recent 1-year high of $9.36. The company’s stock price has